Dealmakers newsletter: May 2008
Welcome to May's edition of the Dealmakers newsletter from CurrentPartnering.
Sponsored by: Intralinks | Verticali | EuroPLX | DMS Data Systems
If not already signed up to receive our newsletters, do so here.
In this issue:
- Editor's corner
- New partnering reports
- In the news - May 2008
- New best practice articles
- Forthcoming events
- Scorecards - newly updated with latest deals
- People on the move
- Partnering resources: Online partnering
- Glossary of partnering terms
The May issue of Dealmakers is sponsored by:
EuroPLX 36
Historically, this partnering event delivers an average of more than 23 pre-scheduled appointments per participating company for Collaborative Agreements in Prescription Drugs from Clinical Candidates to Value Added Generics - Development, Licensing, Marketing and Distribution.
In addition, attending companies are expected to offer or look for R&D services, supporting technologies, contract manufacture, and the supply of APIs and intermediates.
For more information, please log on to http://www.europlx.com
EDITOR'S CORNER
Dealmaking has now started to pick up in 2008.
Hot off the press is the news that Ranbaxy has signed a drug discovery development pact with Merck - the companies will work together to develop clinically validated anti-bacterial and anti-fungal drug candidates.
Also of interest is the conclusion of Abbott and Takeda's TAP joint venture; Forest and Daiichi Sankyo's terminated AZOR co-promotion agreement; and Bristol-Myers Squibb's intention to sell its ConvaTec unit for $4.1 billion.
Our latest report Manufacturing and Supply Agreements in Biopharma provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the worlds leading biopharma companies.
The report complements our other recent reports: Merger and Acquisitions Agreements in Biopharma; Co-promotion and Co-marketing Agreements in Biopharma; and Distribution Agreements in Biopharma.
You can also view the leading deals so far this year in our updated Scorecards.
Until next time - happy dealmaking!
- Steve Poile
NEW PARTNERING REPORTS
Manufacturing and Supply Agreements in Biopharma
The Manufacturing and Supply Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the manufacturing and supply partnering agreements entered into by the worlds leading biopharma companies Manufacturing and Supply Agreements in Biopharma
Distribution Agreements in Biopharma
The Distribution Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the distribution partnering agreements entered into by the worlds leading biopharma companies Distribution Agreements in Biopharma
Bigpharma Partnering Agreements
The Bigpharma Partnering Agreements report provides comprehensive and unprecedented access to the partnering agreements entered into by the worlds leading fifty biopharma companies Bigpharma Partnering Agreements
Merger and Acquisition Agreements in Biopharma
The Merger and Acquisition Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies Merger and Acquisition Agreements in Biopharma
Co-promotion & Co-marketing Agreements in Biopharma
The Co-promotion and Co-marketing Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies Co-promotion & Co-marketing Agreements in Biopharma
Also:
Practical Guide to Finding Partners in Biopharma
CurrentPartnering’s Practical Guide to Finding Partners in Biopharma provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity Practical Guide to Finding Partners in Biopharma
IN THE NEWS
The latest partnering developments - May 2008:
- Ranbaxy signs drug discovery development pact with Merck & Co
- Forest and Daiichi Sankyo terminate AZOR co-promotion agreement
- SomaLogic and Otsuka enter research collaboration
- ACT Biotech acquires clinical and early stage oncology portfolio licenses from Bayer HealthCare
- Bristol-Myers Squibb to sell ConvaTec unit for $4.1 billion
- Galapagos and Allergan enter drug discovery collaboration
- QSV Biologics awarded cGMP manufacturing contract by Pfizer
- Roche exercises option to develop and commercialize Memory Pharmaceuticals nicotinic alpha-7 agonist, MEM 3454
- Abbott and Takeda conclude TAP joint venture
- Entelos enter in silico research agreement with Eli Lilly
NEW BEST PRACTICE ARTICLES
BioEurope Spring Facilitates Partnering on a Massive Scale
Leaders from the biotechnology and pharmaceutical industries gathered last week for the 2nd annual BIO-Europe Spring partnering conference read more
The Role of Competition in Bio-Technological Patenting and Innovation
This article examines the phenomenon of patenting as a strategy not so much to protect innovations but as a means of securing bargaining chips for access to others’ proprietary technologies read more here
FORTHCOMING EVENTS
Here is our suggested partnering events for summer/fall 2008.
Healthcare Investor & Corporate Development Conference 2008
Chicago, Il, USA - May 13-14, 2008
SRI’s annual event is highly regarded in the industry and well attended by healthcare CEOs, CFOs, business development officers and the financial & investment community including commercial & investment banking, private equity, LBO, venture funds, institutional investors, M&A specialists and senior, mezzanine and other lenders Healthcare Investor & Corporate Development Conference 2008
EuroPLX 36 Istanbul
Istanbul, Turkey - June 9-10, 2008
Collaborative agreements in prescription drugs from clinical candidates to value added generics - development, licensing, marketing and distribution EuroPLX 36 Istanbul
BIO Business Forum 2008
San Diego, CA, USA - June 17-20, 2008
The leading biopharma partnering meeting BIO Business Forum 2008
BioPharm America 2008
Buckland, Atlanta, USA - September 9-10, 2008
BioPharm America is where biotech industry partnerships get started. Based on the same winning formula used in EBD Group’s distinguished European partnering conferences BIO-Europe and BIO-Europe Spring, BioPharm America is expected to become the premier stand-alone bio-pharma partnering event in North America BioPharm America 2008
BioBusiness Network 2008
Geneva, Switzerland - September 16-18, 2008
The Premier Global Bio-Partnering Event BioBusiness Network 2008
SCORECARDS
Our scorecards are updated with the latest deals to break into our most valuable deal rankings - the latest deal for 2008 to enter our partnering top 20 is Astellas and CoMentis's $760m deal CoMentis’ beta-secretase inhibitor program, including CoMentis’ lead candidate compound CTS-21166, an orally bioavailable, small-molecule beta-secretase inhibitor which is being developed as a disease-modifying treatment for Alzheimer’s disease.
- Partnering Top 20 - 2008
- Partnering Top 20 - 2007
- Partnering since 2000
- M&A Top 20 - 2008
- M&A Top 20 - 2007
- M&A since 2000
- Bigpharma Top 25 partnering - 2007
PEOPLE ON THE MOVE
The following people have been reported on the move during the weeks of May 2008:
Patricia Williams, Kareem Saad, Michael Staff, Jean-Christophe Tellier, Reginald Seeto, Saeid Babaei, Vincent Angotti to name just a few
read more about the latest people on the move
If you have news about a business development executive who is on the move - let us know
PARTNERING RESOURCES: ONLINE PARTNERING
This month saw the launch of yet another online IP marketplace - Planet Eureka, as well as the launch of WikiPatents Marketplace, so it seems appropriate to provide a link to our comprehensive listing of online partnering services - Online partnering
GLOSSARY: UPDATED PARTNERING TERMS
The most recent addition is SPC or Supplementary Protection Certificate - a concession granted to pharma to extend protection under a patent more details
Full Glossary can be accessed here
Do you have specific glossary terms that you would like to see in our website? Give us your ideas here
CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers
Advertizing and sponsorship
CurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online.
or contact us to discuss your requirements.
Steve Poile, Editor
Web: http://www.CurrentPartnering.com
Mail: Current Partnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom
Tel: +44 7896 656732
Fax: +44 8703 305993
Scorecard Index
Deal term reports
The information you provide is excellent and we look forward to doing more business with you in the future
...You have published very timely and interesting materials.... I am excited.... It is an excellent publication and pretty well up to date...
CurrentPartnering Reports
The latest reports on best practise for dealmakers available from CurrentPartnering
Quick links
Term of the week...
Heads of agreement A pre-agreed document that outlines the key elements and structure of the planned deal.